JPRN-UMIN000016879
Completed
未知
Mutation analyses of plasma and tumor DNA in EGFR mutation-positive advanced non-small-cell lung cancer. - Liquid Biopsy Study
Clinical Research Support Center Kyushu0 sites100 target enrollmentMarch 23, 2015
Conditionsnon-small-cell lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-small-cell lung cancer
- Sponsor
- Clinical Research Support Center Kyushu
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patient with positive HBs antigen or HVC antibody. 2\) Patient with definite positive HIV antibody (need not for examination). 3\) Any other patients who are regarded as unsuitable for this study by the investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
EGFR-mutation analysis of circulating tumor DNA with high sensitive methods and concordance to effect of EGFR-TKI.JPRN-UMIN000016348Miyagi Cancer Center30
Completed
Not Applicable
Monitoring study of genomic mutations in patients with EGFR mutation or ALK translocation using plasma DNAnon-small-cell lung cancerJPRN-UMIN000035628Wakayama Medical University100
Completed
Not Applicable
Monitoring EGFR mutation status with cell-free DNA: a prospective exploratory analyses of phase Ib study of osimertinib plus ramucirumab in lung adenocarcinoma patients with EGFR T790M mutatioung CancerJPRN-UMIN000030164Wakayama Medical University3
Recruiting
Not Applicable
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatmentnon-small cell lung cancerJPRN-UMIN000037232Advanced Cancer Translational Research Institute100
Completed
Not Applicable
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60